المؤلفون: Boonstra PA; University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Hanzeplein 1, 9713, GZ, Groningen, the Netherlands., Steeghs N; Netherlands Cancer Institute, Antoni van Leeuwenhoek, Department of Medical Oncology, Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands., Farag S; Netherlands Cancer Institute, Antoni van Leeuwenhoek, Department of Medical Oncology, Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands., van Coevorden F; Netherlands Cancer Institute, Antoni van Leeuwenhoek, Department of Surgical Oncology, Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands., Gelderblom H; Leiden University Medical Center, Department of Medical Oncology, P.O. Box 9600, 2300, RC, Leiden, the Netherlands., Grunhagen DJ; Erasmus MC - Cancer Institute, Department of Surgical Oncology, s Gravendijkwal 230, 3015, CE, Rotterdam, the Netherlands., Desar IME; Radboud University Medical Center, Department of Medical Oncology, P.O. Box 9101, 6500, HB, Nijmegen, the Netherlands., van der Graaf WTA; Radboud University Medical Center, Department of Medical Oncology, P.O. Box 9101, 6500, HB, Nijmegen, the Netherlands., Bonenkamp JJ; Radboud University Medical Center, Department of Surgical Oncology, P.O. Box 9101, 6500, HB, Nijmegen, the Netherlands., Reyners AKL; University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Hanzeplein 1, 9713, GZ, Groningen, the Netherlands., van Etten B; University of Groningen, University Medical Center Groningen, Department of Surgical Oncology, Hanzeplein 1, 9713, GZ, Groningen, the Netherlands. Electronic address: b.van.etten@umcg.nl.

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2019 Mar; Vol. 45 (3), pp. 410-415. Date of Electronic Publication: 2018 Oct 16.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Staging*, Antineoplastic Agents/*therapeutic use , Digestive System Surgical Procedures/*methods , Gastrointestinal Neoplasms/*therapy , Gastrointestinal Stromal Tumors/*therapy, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Gastrointestinal Neoplasms/diagnosis ; Gastrointestinal Neoplasms/epidemiology ; Gastrointestinal Stromal Tumors/diagnosis ; Gastrointestinal Stromal Tumors/epidemiology ; Humans ; Male ; Middle Aged ; Morbidity/trends ; Netherlands/epidemiology ; Positron Emission Tomography Computed Tomography ; Prognosis ; Prospective Studies ; Survival Rate/trends ; Young Adult

المؤلفون: van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK., Tielen R; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Surgical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Bonenkamp JJ; Department of Surgical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Lemmens V; Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Verhoeven RHA; Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., de Wilt JHW; Department of Surgical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.

المصدر: The British journal of surgery [Br J Surg] 2018 Jul; Vol. 105 (8), pp. 1020-1027. Date of Electronic Publication: 2018 Apr 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press on behalf of BJS Foundation Ltd Country of Publication: England NLM ID: 0372553 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2168 (Electronic) Linking ISSN: 00071323 NLM ISO Abbreviation: Br J Surg Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Gastrointestinal Stromal Tumors/*epidemiology , Imatinib Mesylate/*therapeutic use, Adolescent ; Adult ; Aged ; Digestive System Surgical Procedures/statistics & numerical data ; Female ; Gastrointestinal Stromal Tumors/mortality ; Gastrointestinal Stromal Tumors/therapy ; Humans ; Incidence ; Male ; Middle Aged ; Netherlands/epidemiology ; Registries ; Survival Rate

المؤلفون: Tielen R; Department of Surgical Oncology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 10, 6525 GA Nijmegen, The Netherlands. r.tielen@chir.umcn.nl, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink HH, Bonenkamp JJ, van der Graaf WT, de Wilt JH

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2013 Feb; Vol. 39 (2), pp. 150-5. Date of Electronic Publication: 2012 Oct 16.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Gastrectomy*, Antineoplastic Agents/*therapeutic use , Gastrointestinal Neoplasms/*pathology , Gastrointestinal Neoplasms/*surgery , Gastrointestinal Stromal Tumors/*pathology , Gastrointestinal Stromal Tumors/*surgery , Piperazines/*therapeutic use , Pyrimidines/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Benzamides ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Gastrointestinal Neoplasms/drug therapy ; Gastrointestinal Neoplasms/mortality ; Gastrointestinal Stromal Tumors/drug therapy ; Gastrointestinal Stromal Tumors/mortality ; Humans ; Imatinib Mesylate ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoadjuvant Therapy/methods ; Neoplasm Staging ; Netherlands/epidemiology ; Piperazines/administration & dosage ; Piperazines/adverse effects ; Pyrimidines/administration & dosage ; Pyrimidines/adverse effects ; Retrospective Studies ; Time Factors ; Treatment Outcome